Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor‐Induced Blood Pressure Rise: A Clinical Cohort Study

por van Dorst, Daan C. H., Kabadayi, Sumeyye, Oomen‐de Hoop, Esther, Danser, A.H. Jan, Mathijssen, Ron H. J., Versmissen, Jorie
Publicado 2022

Transforming Growth Factor-β and the Renin-Angiotensin System in Syndromic Thoracic Aortic Aneurysms: Implications for Treatment

por van Dorst, Daan C.H., de Wagenaar, Nathalie P., van der Pluijm, Ingrid, Roos-Hesselink, Jolien W., Essers, Jeroen, Danser, A.H. Jan
Publicado 2020

Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients

por van Dorst, Daan C.H., Dobbin, Stephen J.H., Neves, Karla B., Herrmann, Joerg, Herrmann, Sandra M., Versmissen, Jorie, Mathijssen, Ron H.J., Danser, A.H. Jan, Lang, Ninian N.
Publicado 2021

Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension

por van Doorn, Leni, Visser, Wesley J., van Dorst, Daan C. H., Mirabito Colafella, Katrina M., Koolen, Stijn L. W., de Mik, Anneke van Egmond-, Garrelds, Ingrid M., Bovée, Dominique M., de Hoop, Esther Oomen-, Bins, Sander, Eskens, Ferry A. L. M., Hoorn, Ewout J., Jan Danser, A. H., Mathijssen, Ron H. J., Versmissen, Jorie
Publicado 2022

Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage

por Mirabito Colafella, Katrina M., van Dorst, Daan C.H., Neuman, Rugina I., Doorn, Leni van, Neves, Karla Bianca, Montezano, Augusto C., Garrelds, Ingrid M., van Veghel, Richard, de Vries, René, Uijl, Estrellita, Clahsen-van Groningen, Marian C., Baelde, Hans J., van den Meiracker, Anton H., Touyz, Rhian M., Visser, Willy, Danser, A.H. Jan, Versmissen, Jorie
Publicado 2022